Google
MDCX — MEDICUS PHARMA LTD. COMMON STOCK (Healthcare >> Drug Manufacturers - General)
MDCX FAQ
What is MDCX's ROE?
MEDICUS PHARMA LTD. COMMON STOCK reports a Return on Equity (ROE) of -2,785.23%.
What is MDCX's dividend yield?
MEDICUS PHARMA LTD. COMMON STOCK offers a dividend yield of 0.00%.
What is MDCX's Deepscope Quality Score?
Deepscope rates MDCX's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MDCX?
Deepscope's AI Timing Score for MDCX is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MDCX belong to?
MEDICUS PHARMA LTD. COMMON STOCK is classified under the Healthcare >> Drug Manufacturers - General sector on the NASDAQ exchange.
|
USD 0.35
Price
-0.02
(-6.32%)
Day Change
|
|
|---|
MDCX, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.35 |
| PBV / Sector |
13.89 / 2.84
|
| Earning Per Share | -0.65 |
| PE / Sector |
N/A / 24.53
|
| PEG or PE/Growth / Sector |
N/A / 0.08
|
| Average 1M Daily Value |
1.05 M
GREAT
|
| Average 1W Daily Value |
1.05 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:03 |
| Symbol | MDCX |
| Name | MEDICUS PHARMA LTD. COMMON STOCK |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NASDAQ |
| Listed Shares | 56.66 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 19.83 / 241,254.65 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 300 Conshohocken State Road, West Conshohocken, PA, United States, 19428
Phone: 610 636 0184
Website: https://medicuspharma.com
Description: Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
ME vs SECTOR Healthcare >> Drug Manufacturers - General
Click a bubble to view stock details · Bubble size represents market capitalization share
